arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Astrana Health, Inc.

ASTH
$35.71 ▲ +1.60 (+4.69%) at close
Industrials ·Services-Management Consulting Services ·USServices-Management Consulting Services
54 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
48
Health
Weak
Bearish
auto_awesome

Analytical Summary

Astrana Health, Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $1.7B
Dividend Yield
Revenue Growth 55.6%
Op. Margin 3.0%
ROIC 1.1%
FCF / Share $1.31
Trailing P/E 119.0x
Price / Book 2.2x
FCF Yield 3.7%
Debt / Equity 1.22
info Valuation on last close. End-of-day price, Aug 7, 2026.

54-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$965.10M
↑ +55.6%
Net Income Profit after all expenses
$14.44M
↑ +115.7%
Operating Margin Operating profit as % of sales
3.0%
↑ +52.7% 35th
FCF / Share Free cash flow per share
$1.31
↑ +368.8%
Long-Term Debt Long-term obligations
$979.76M
↓ -1.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability
35
Returns
49
Financial Health
40
Cash Quality
95

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 54 quarters